Pentasa (Mesalazine) – Patient-Friendly Guide (UK)

What is Pentasa?
Pentasa is a medicine that contains mesalazine (also called 5-aminosalicylic acid / 5‑ASA). It is used to treat and help prevent flare-ups of certain inflammatory conditions affecting the bowel, particularly ulcerative colitis and (in many cases) crohn’s disease when inflammation is in the colon and/or ileum.

This guide explains how Pentasa works, how it’s taken, what to expect, and important safety information. It is written for patients in the United Kingdom.

Basic product information

• Active ingredient: Mesalazine (5‑ASA)
• Brand name: Pentasa
• Common dosage forms: Enteric-coated granules or tablets depending on product strength and country availability
• How it’s designed to work: Pentasa formulations are typically designed to release mesalazine along the bowel (the exact release profile depends on the product form)
• Medicinal category (UK): Anti-inflammatory bowel medicine (an aminosalicylate)

Note: Brand availability and strengths can vary by supplier and formulation. Always check the pack for exact strength, formulation, and instructions.

How Pentasa works (mechanism of action)

Pentasa helps reduce inflammation in the lining of the bowel. It is thought to act locally (in the intestinal wall) rather than mainly throughout the body.

• Anti-inflammatory action: Mesalazine reduces inflammatory signals within the gut.
• Antioxidant effects: It may help neutralise harmful oxidative activity involved in inflammation.
• Targeted delivery: The way Pentasa releases mesalazine helps deliver the medicine to affected areas of the intestines.

What this means for you: Pentasa is designed to lower inflammation and help maintain remission (when symptoms are controlled). It can also be used to treat active disease, but the time to improvement can vary between individuals.

Pharmacokinetics – how the body handles mesalazine

Although Pentasa works mainly in the bowel, some mesalazine can be absorbed into the bloodstream. Understanding the general process may help you know what to expect.

• Absorption: Mesalazine absorption is generally limited compared with other medicines.
• Distribution: Some absorbed mesalazine circulates in the bloodstream; it acts where needed and is processed by the body.
• Metabolism: Mesalazine is primarily converted in the intestinal wall and liver to N-acetyl-5-ASA (a metabolite).
• Excretion: Metabolites and small amounts of active drug are excreted, mainly through the kidneys and in urine.

Why kidneys matter: Because excretion involves the kidneys, kidney function may be checked during treatment (especially if you have kidney disease or risk factors).

Typical uses in the UK

Pentasa is commonly used in the UK for:

• Ulcerative colitis – for induction and maintenance of remission, including flare prevention
• Crohn’s disease – in selected cases, particularly when disease is limited to the colon or involves the ileum, and when an aminosalicylate is considered appropriate

Important: Treatment choices in inflammatory bowel disease (IBD) depend on location and severity of disease, past response to medicines, and your overall health. Your clinician may adjust therapy over time.

When to take Pentasa – timing and routine

Follow your individual instructions from your healthcare professional and the product label. If you’re unsure, confirm with the pharmacy or your care team.

• Consistency helps: Take Pentasa regularly at the same times each day to maintain steady levels in the gut.
• Morning and evening dosing: Many people take doses split across the day (for example, morning and evening). Some regimens may be once daily depending on formulation and strength.
• Space doses: If you take multiple doses per day, try to keep even spacing.

Missed dose: If you forget a dose, take it as soon as you remember unless it’s close to the next dose. Do not take a double dose to make up for a missed one.

Food interactions – what to know

Pentasa is generally taken without a strict need to avoid food, but it’s helpful to know the practical guidance:

• Most people can take it with or after food to reduce stomach discomfort if they experience it.
• Granules/tablets: Do not change how you take the product unless advised. Some formulations must be swallowed whole, and some granules may have specific instructions for how they should be taken.
• Consistency matters: Try to take it the same way each day (e.g., always with food or always on an empty stomach) unless your clinician advises otherwise.

If you have reflux, nausea, or swallowing difficulties, check the product instructions carefully or ask a pharmacist for guidance on how to take your specific Pentasa formulation.

Alcohol and medicine interactions

Alcohol: There is no universal rule that alcohol is absolutely contraindicated with mesalazine. However, alcohol may worsen stomach irritation and can affect hydration and sleep, which may influence IBD symptoms during flares.

• During active disease: It’s often best to limit or avoid alcohol, as symptoms such as diarrhoea and abdominal discomfort may be more noticeable.
• Watch your tolerance: If you notice symptoms worsen after alcohol, reduce intake or avoid it.

Medicine interactions: Always inform your pharmacist or clinician about all medicines and supplements you use. Key interaction themes include:

• Kidney-related risks: If you take medicines that can affect kidney function (for example, certain non-steroidal anti-inflammatory drugs—NSAIDs—or medicines known to affect renal blood flow), your care team may monitor you more closely.
• Azathioprine/mercaptopurine: Sometimes used in IBD. Combined therapy may require blood and liver monitoring under specialist care.
• Warfarin (and other anticoagulants): If you use blood thinners, ask a clinician or pharmacist if any extra monitoring is needed.
• Diuretics and antihypertensives: If you take blood pressure medicines, let your team know—monitoring may be advised if kidney function is a concern.

Tip: Bring a list of your current medicines to your pharmacy consultation. This makes it easier to spot interaction risks early.

Indications – who Pentasa is for

Pentasa is indicated for inflammatory bowel diseases where aminosalicylates are appropriate. In UK practice, this usually includes:

• Ulcerative colitis: To manage active inflammation and help maintain remission.
• Crohn’s disease: Selected patients, particularly with inflammation in the colon and/or ileum, depending on severity and clinical judgement.

It may not suit everyone with IBD. People with severe disease, extensive involvement, or complications may require other medicines (for example, steroids, immunomodulators, biologics, or surgery).

Dosing – general guidance and how doses are determined

Dosing is individual and depends on the condition being treated, severity, and your response. The exact dose for you should come from the product label and your care plan.

General typical adult dosing (informational):

• Ulcerative colitis: Common regimens may involve multiple daily doses totalling several grams per day (strength and number of sachets/tablets vary by product).
• Crohn’s disease: Often similar dosing ranges are used, tailored to disease location and response.

How to use your prescribed/labelled strength:

Children and adolescents: Dosing may differ and should be specifically calculated based on age and weight, using specialist guidance.

Safety profile – what to watch for

Like all medicines, Pentasa (mesalazine) can cause side effects. Many people tolerate it well, but you should be aware of potential reactions.

Common or expected side effects

• Nausea
• Headache
• Abdominal discomfort
• Diarrhoea or changes in bowel habits (may be difficult to distinguish from IBD symptoms)
• Flatulence

Serious side effects – seek urgent medical advice

Seek urgent advice if you develop signs of a serious reaction, such as:

• Allergic reaction: swelling of the face/lips, breathing difficulty, widespread rash, severe itching
• Severe worsening of symptoms: severe abdominal pain, marked diarrhoea, fever
• Kidney problems: reduced urine output, swelling (hands/feet/face), unusual fatigue
• Lung reactions (rare): new persistent cough, chest pain, shortness of breath
• Blood disorders (rare): unusual bruising, persistent sore throat, significant tiredness

Monitoring: Your clinician may arrange blood and urine tests periodically, particularly to monitor kidney function and blood counts. This is a common precaution with mesalazine-containing medicines.

When to be extra careful

• If you have kidney disease or a history of kidney problems
• If you have a history of mesalazine or salicylate intolerance
• If you have asthma or previous allergic reactions to similar medicines
• If you are taking multiple medicines that could affect the kidneys
• If you are pregnant or breastfeeding (discuss a plan with your healthcare team)

Practical use tips (how to take Pentasa correctly)

• Use the exact product instructions: Different Pentasa forms may have different administration requirements.
• Do not crush or chew unless instructed: Some formulations are designed to release in the bowel; crushing or chewing may change how it releases.
• Granules and sachets: If your product is granules, follow the pack instructions on how to take them (some may be mixed with liquid/food only if the label permits).
• Stay hydrated: During active bowel symptoms, dehydration can worsen your overall condition.
• Keep a routine: Use a daily alarm, calendar reminder, or pill organiser to reduce missed doses.
• Know your flare signs: Contact your clinician if you notice symptoms escalating or failing to improve.

Timing to expect benefits

People often notice improvement within days to weeks, but it can vary. For maintenance (keeping disease under control), consistent long-term use is important—even if you feel well.

• Active flare: Some improvement may occur within 1–4 weeks, though this is not guaranteed.
• Maintenance: Taking Pentasa regularly can help reduce the frequency and severity of flares.
• Don’t stop suddenly: Stopping without medical advice may increase the chance of relapse.

Alternative options (if Pentasa isn’t suitable)

Several other medicines can be used for ulcerative colitis and some cases of Crohn’s disease. Alternatives depend on your disease severity, location, previous response, and tolerance.

Other aminosalicylates

• Mesalazine (other brands/formulations): Different release profiles may be used by specialists.
• Olsalazine or balsalazide (availability varies in the UK)

Other medicine classes used in IBD

• Corticosteroids: Often for short-term control of flares
• Immunomodulators: Such as azathioprine/mercaptopurine in some people
• Biologic therapies: For moderate-to-severe disease or inadequate response to standard treatments
• Other anti-inflammatory or targeted therapies: Depending on disease and risk factors

Rectal therapy: For left-sided ulcerative colitis, some patients use mesalazine suppositories or enemas as an adjunct. Your clinician will advise the best approach.

Market and legal context in the United Kingdom

In the UK, mesalazine-containing medicines are widely used for inflammatory bowel disease. Medication availability and supply can change over time depending on licensing, manufacturing status, and local pharmacy distribution arrangements.

Regulation and quality: Medicines sold through legitimate UK channels must meet regulatory requirements for quality, safety, and distribution. Your pharmacy supplier should provide accurate product information and appropriate packaging.

Guideline-based care: IBD treatment is typically guided by clinical assessment and evidence-based recommendations. Mesalazine is a cornerstone option for many patients with ulcerative colitis, especially for mild-to-moderate disease and maintenance.

Recent guidance and clinical practice notes (UK context)

Clinical guidance in IBD evolves through updates to practice recommendations and safety monitoring approaches. While individual care plans vary, common themes in UK practice include:

• Stratified treatment: Treatment intensity is selected based on disease severity and response.
• Maintenance strategy: Continuing effective therapy helps prevent relapse.
• Monitoring: Regular checks (often including blood tests and kidney function) to reduce risk and detect early problems.
• Patient education: Emphasis on understanding how to take medicines correctly and when to seek medical advice.

If you’re concerned about current best practice for your situation, ask your clinician or pharmacist about the most appropriate monitoring schedule for your health history.

Delivery and availability (online pharmacy)

Availability can vary by formulation and strength. When ordering online in the UK, you typically need to ensure the product you select matches the exact medicine and strength you are using.

• Dispatch times: Many UK pharmacies dispatch quickly if stock is available; otherwise, lead times can apply.
• Delivery options: Standard and express delivery may be offered depending on the supplier.
• Packaging: Medicines are usually delivered in tamper-evident packaging.
• Storage: Follow pack instructions for storage conditions (often “store below 25°C” or similar guidance, depending on the product).

If you’re restarting after a break: Check expiry dates and confirm you still have the correct formulation and strength.

FAQ – Pentasa (Mesalazine)

1) Is Pentasa the same as mesalazine?

Yes. Pentasa contains mesalazine, an aminosalicylate used to treat inflammation in the bowel.

2) How long does it take to work?

Some people feel better within days to weeks, but it can take longer. If symptoms do not improve or worsen, contact a healthcare professional for advice.

3) Can I stop Pentasa when I feel better?

Typically, Pentasa is used long-term for maintenance. Stopping abruptly may increase the risk of flare. Discuss any changes with your clinician or pharmacist.

4) What if I miss a dose?

Take it when you remember unless it’s almost time for the next dose. Do not take a double dose to make up for a missed one.

5) Can I take Pentasa with food?

Many patients can take it with or after food. Follow the pack instructions for your specific formulation.

6) Are there foods or drinks I should avoid?

There are no specific universal food prohibitions, but alcohol may worsen symptoms for some people, especially during flares. Focus on staying well hydrated and maintaining a diet that suits your symptoms.

7) Can I drink alcohol while taking Pentasa?

Moderation is recommended. If alcohol worsens diarrhoea or abdominal discomfort, avoid it. During active flare-ups, it’s often best to limit or avoid alcohol.

8) Does Pentasa affect the kidneys?

Mesalazine medicines are generally well tolerated, but kidney effects can occur rarely. Your clinician may monitor kidney function with blood and urine tests, especially if you have existing kidney problems.

9) What side effects should make me contact a doctor urgently?

Seek urgent advice for signs of a serious allergic reaction, severe worsening of bowel symptoms, persistent fever, reduced urination or swelling, severe breathlessness, or chest pain.

10) Can Pentasa be used in pregnancy or breastfeeding?

Some patients may use mesalazine in pregnancy or breastfeeding depending on the situation. If you’re pregnant, planning pregnancy, or breastfeeding, discuss risks and benefits with your healthcare team.

Summary

Pentasa (mesalazine) is an anti-inflammatory bowel medicine used to manage ulcerative colitis and selected cases of crohn’s disease. It works mainly in the gut lining to reduce inflammation. Many people tolerate it well, but kidney monitoring and awareness of side effects are important.

To get the best benefit:

• Take it consistently at the right times
• Follow the instructions for your exact formulation
• Keep up with monitoring appointments if your clinician recommends blood/urine tests
• Seek advice if symptoms worsen or you notice signs of serious side effects